TrueTicker

NIFTY 500 › Healthcare

Healthcare · NIFTY 500

Concord Biotech Ltd.

CONCORDBIO on NSE · 19 Nov 2026

NIFTY 500

556.40 ▼ -0.82 % on the day

Overview Technical Risk & rank Quality Results Accounts Filings Guidance & governance

Quarterly results

The last 12 quarters, and the day after each.

QuarterRevenueYoYProfitYoYMarginEPSResult dateNext-day move
Q2 FY27 (Jul-Sep 2026)309+25.1 % 71+11.1 %22.9 %6.65 27 Oct 2026-7.8 %
Q1 FY27 (Apr-Jun 2026)257+26.2 % 59+32.8 %22.7 %5.52 31 Jul 2026-0.4 %
Q4 FY26 (Jan-Mar 2026)326-24.1 % 89-36.8 %27.2 %8.46 29 May 2026+1.0 %
Q3 FY26 (Oct-Dec 2025)278+13.7 % 64-15.1 %23.2 %6.08 11 Feb 2026-1.3 %
Q2 FY26 (Jul-Sep 2025)247-20.4 % 64-33.6 %25.7 %6.03 13 Nov 2025+2.8 %
Q1 FY26 (Apr-Jun 2025)204-5.5 % 44-26.1 %21.6 %4.21 08 Aug 2025+0.4 %
Q4 FY25 (Jan-Mar 2025)430+34.8 % 140+47.8 %32.7 %13.42 29 May 2025+4.9 %
Q3 FY25 (Oct-Dec 2024)244+1.4 % 76-2.1 %31.1 %7.26 14 Feb 2025-19.9 %
Q2 FY25 (Jul-Sep 2024)310+18.2 % 96+18.2 %30.9 %9.15 12 Nov 2024-1.1 %
Q1 FY25 (Apr-Jun 2024)216+10.8 % 60+9.4 %27.6 %5.70 09 Aug 2024-2.0 %
Q4 FY24 (Jan-Mar 2024)319- 95-29.8 %9.08 24 May 2024-0.5 %
Q3 FY24 (Oct-Dec 2023)241- 78-32.2 %7.41 09 Feb 2024-1.2 %

₹ cr, consolidated; EPS in ₹ a share, as reported. YoY: against the same quarter last year. Next-day move: the share's move on the first trading day after the result. A dash means the figure is not available; nothing is estimated.

Financial years

The years these quarters add up to.

Year to MarchRevenueYoYProfitYoYMarginEPS
FY261,055-12.1 % 261-29.8 %24.7 %24.78
FY251,200+18.0 % 372+20.6 %31.0 %35.53
FY241,017- 308-30.3 %29.44

A year is the sum of its four reported quarters, shown only when all four are available; it can differ a little from the audited annual figures. Results start from Q1 FY24 (Apr-Jun 2023).

Ask Sensei

Ask Sensei

Ask about any NIFTY 500 company in plain words. The answer comes from its own filings, with the page behind every point.

For example:

See a sample answer

Start free Sign in